Endo Health Solutions (NASDAQ:ENDP) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research note issued to investors on Wednesday, Analyst RN reports. They currently have a $70.00 target price on the stock. Zacks‘ price target would suggest a potential upside of 4.52% from the stock’s previous close. Zacks‘ analyst […]
Endo Health Solutions Downgraded by Zacks to Neutral (ENDP) is a post from: Zolmax
The post Endo Health Solutions Downgraded by Zacks to Neutral (ENDP) appeared first on Zolmax.